Playback speed
10 seconds
SGO 2024 Insights: "The Use of Rucaparib vs. Placebo Maintenance Therapy in Metastatic & Recurrent Endometrial Cancer"
By
Insights from 2024 SGO Annual Meeting
FEATURING
Bradley Corr
By
Insights from 2024 SGO Annual Meeting
FEATURING
Bradley Corr
0 views
March 29, 2024
Comments 0
Login to view comments.
Click here to Login